Literature DB >> 19042263

Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group study.

Patrick O Monahan1, Victoria L Champion, Qianqian Zhao, Anna M Miller, David Gershenson, Stephen D Williams, David Cella.   

Abstract

Ovarian germ cell cancer is a rare tumor. Approximately 1000 to 2000 women in the United States will be diagnosed with ovarian germ cell cancer in 2007. When it occurs, it is usually diagnosed before age 20 and is highly responsive to therapy. Most patients live a full life span. The 5-year relative survival rate is 95%. This article describes differences in quality of life issues between ovarian germ cell cancer survivors and young women who have not experienced cancer and were matched to survivors on age, education, and race (by the acquaintance control method). Survivors and controls completed mail and phone surveys. A multivariable logistic regression model was adjusted for age, education, household income, marital status, and perception of fertility. Compared to controls, germ cell cancer survivors expressed more reproductive concerns and reported worse sexual functioning, but they also experienced greater appreciation of life and more affective (i.e., emotional) social support. Future research is suggested to test interventions to enhance quality of life for ovarian germ cell cancer survivors in the areas of sexual functioning and reproductive concerns, but only for survivors who are in distress or in need of the support. Potential screening questions are offered for clinicians, but further research is needed to assess their validity as screening tools.

Entities:  

Mesh:

Year:  2008        PMID: 19042263     DOI: 10.1080/07347330802115715

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  9 in total

Review 1.  Quality of life for donors after living donor liver transplantation: a review of the literature.

Authors:  Neehar D Parikh; Daniela Ladner; Michael Abecassis; Zeeshan Butt
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

2.  Women with Ovarian Cancer: Examining the Role of Social Support and Rumination in Posttraumatic Growth, Psychological Distress, and Psychological Well-being.

Authors:  Erin M Hill; Kaitlin Watkins
Journal:  J Clin Psychol Med Settings       Date:  2017-03

3.  Nursing research in the Gynecologic Oncology Group.

Authors:  Heidi S Donovan; Susan Nolte; Robert P Edwards; Lari Wenzel
Journal:  Semin Oncol Nurs       Date:  2013-12-19       Impact factor: 2.315

4.  Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.

Authors:  Daniela Matei; Anna M Miller; Patrick Monahan; David Gershenson; Qianqian Zhao; David Cella; Victoria L Champion; Stephen D Williams
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

Review 5.  Ovarian cancer survivors' quality of life: a systematic review.

Authors:  D Ahmed-Lecheheb; F Joly
Journal:  J Cancer Surviv       Date:  2016-02-17       Impact factor: 4.442

Review 6.  Issues of ovarian cancer survivors in the USA: a literature review.

Authors:  Katrina F Trivers; Jennifer Rees Patterson; Katherine B Roland; Juan L Rodriguez
Journal:  Support Care Cancer       Date:  2013-07-12       Impact factor: 3.603

7.  Feasibility test of a UK-scalable electronic system for regular collection of patient-reported outcome measures and linkage with clinical cancer registry data: the electronic Patient-reported Outcomes from Cancer Survivors (ePOCS) system.

Authors:  Laura Ashley; Helen Jones; David Forman; Alex Newsham; Julia Brown; Amy Downing; Galina Velikova; Penny Wright
Journal:  BMC Med Inform Decis Mak       Date:  2011-10-26       Impact factor: 2.796

Review 8.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

9.  Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Authors:  Maria Lee; Yumi Lee; Kidong Kim; Eun Young Park; Myong Cheol Lim; Jung-Sup Kim; Hee Seung Kim; Yong-Beom Kim; Yong-Man Kim; Jungnam Joo; Sang Yoon Park; Chel Hun Choi; Jae-Hoon Kim
Journal:  Cancer Res Treat       Date:  2018-03-07       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.